Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - car+t-cell+enhancing+technology
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Compositions and Methods for Enhancing the Anti-Tumor Activity of CAR T Cells by Co-Expression of CH25H
Co-expression of modified chimeric antigen receptor (CAR) T cells and cholesterol 25-hydroxylase (CH25H) in a single construct for treatment of solid tumor and hematological cancers. Problem: CAR T cell therapy is a treatment in which T cells collected from a patient are engineered to produce CARs that recognize and attack cancer cells. While it...
Published: 7/11/2024
|
Inventor(s):
Serge Fuchs
,
Noreen McBrearty
,
Zhen Lu
Keywords(s):
Bioengineering
,
CAR T-cell Enhancing Technology
,
Cell Therapy
,
Immunoncology
,
Immunotherapy
,
Oncology
,
Platform Technology
Category(s):
Technology Classifications > Therapeutics
CD137 enrichment of tumor-specific tumor-infiltrating lymphocytes (TILs)
A platform to isolate and expand CD137-positive (CD137pos) tumor-infiltrating lymphocytes (TILs) to use in adoptive immunotherapy and translational studies. Problem: Adoptive immunotherapy using either naturally occurring or genetically modified tumor-infiltrating lymphocytes (TILs) is being developed to treat solid tumors clinically. However, methods...
Published: 11/11/2024
|
Inventor(s):
Daniel Powell
Keywords(s):
CAR T-cell Enhancing Technology
,
Cell Therapy
,
Immunology
,
Immunoncology
,
Immunotherapy
,
Oncology
,
Platform Technology
Category(s):
Technology Classifications > Research Tools & Reagents
,
Technology Classifications > Therapeutics
,
Technology Classifications > Vaccines
Single viral vector for expression of both CAR/TCR and immune modulators for cancer immunotherapy
A single lentiviral vector system as an expression platform for constitutive immune receptor expression and inducible antigen-dependent immunomodulatory molecule expression in primary immune cells for enhanced immunotherapy efficacy Problem: Adoptive cancer immunotherapy, like chimeric antigen receptor T cell (CAR T) therapy, has had extraordinary...
Published: 11/11/2024
|
Inventor(s):
Daniel Powell
,
Anze Smole
,
Avery Posey
Keywords(s):
CAR T-cell Enhancing Technology
Category(s):
Technology Classifications > Research Tools & Reagents
,
Technology Classifications > Therapeutics